STADA Arzneimittel AG
STADA Arzneimittel AG (‘STADA') is a German-headquartered leading manufacturer of prescription generics (off-patent) and over the counter (‘OTC') pharmaceutical products.
STADA has a portfolio of high quality, low cost generic products with a presence across more than 30 markets and strong positions in key countries. Its OTC exposure is highly diversified with a large portfolio of strong local brands.
STADA is headquartered in Bad Vilbel, near Frankfurt, and has over 10,000 employees based in offices across Europe, MENA and Asia. The company was founded as a co-operative of German pharmacists in 1895 and listed its shares on the Frankfurt Stock Exchange in the 1970s.
Cinven, together with Bain Capital, acquired a majority holding in the company through a voluntary public takeover offer in August 2017, building on a number of successful Cinven investments in the pharmaceuticals sector.